# Apeiron Synthesis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apeiron-synthesis-s-a

- Industry: Chemicals
- Headquarters: Wroclaw, Poland
- Website: http://www.apeiron-synthesis.com
- Total disclosed funding: $4.8M
- Latest round: Seed (Dec 21, 2022)
- Investors on record: 3

## About

Based in Wroclaw, Poland, and founded in 2009 Apeiron Synthesis S.A. provides olefin methatesis technology to the chemical industry. In December 2022, the firm raised USD 4.8 million in venture funding from investors Adamed Pharma S.A., Aper Ventures, and Orlen VC. The company was founded by Dr. Michal Bieniek (CEO), Lukasz Gulajski, Krzysztof Skowerski, and Prof. Karol Grela MAE.

The company offers a wide range of services such as Olefin metathesis consulting, catalysts screening, process development, custom catalyst development, product development, and kilo-scale synthesis. Additionally, the firm provides catalysts and polymers which include nitro – Grela, UltraLatMet, UltraCat, UltraNitroCat, ROMP catalysts, and many more. The firm catalyst is used in pharmaceuticals, flavors, and fragrances as well as in the production of polymers and rubber. The firm customer base includes 279 clients and has delivered 25 commercial projects.

## Funding rounds

- Seed, Dec 21, 2022, $4.8M — Adamed Pharma S.A., Orlen VC, Aper Ventures

## Investors

- Adamed Pharma S.A. — Seed
- Orlen VC (https://capitalatlas.ai/funds/orlen-vc) — Seed
- Aper Ventures (https://capitalatlas.ai/funds/aper-ventures) — Seed